Premium
Letter: tenofovir may be superior to entecavir for treatment‐naïve chronic hepatitis B patients—authors’ reply
Author(s) -
Pol Stanislas,
Lusivika Nzinga Clovis,
Carrat Fabrice
Publication year - 2021
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.16340
Subject(s) - entecavir , tenofovir , medicine , chronic hepatitis , gastroenterology , virology , lamivudine , virus , human immunodeficiency virus (hiv)